- Home
- BCRX vs CLBK Comparison
BCRX vs CLBK Comparison
Compare BCRX & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CLBK
- Stock Information
- Founded
- BCRX 1986
- CLBK 1927
- Country
- BCRX United States
- CLBK United States
- Employees
- BCRX N/A
- CLBK N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CLBK Savings Institutions
- Sector
- BCRX Health Care
- CLBK Finance
- Exchange
- BCRX Nasdaq
- CLBK Nasdaq
- Market Cap
- BCRX 1.7B
- CLBK N/A
- IPO Year
- BCRX 1994
- CLBK N/A
- Fundamental
- Price
- BCRX $9.00
- CLBK $14.95
- Analyst Decision
- BCRX Strong Buy
- CLBK Hold
- Analyst Count
- BCRX 10
- CLBK 1
- Target Price
- BCRX $16.70
- CLBK $16.00
- AVG Volume (30 Days)
- BCRX 3.6M
- CLBK 132.2K
- Earning Date
- BCRX 08-04-2025
- CLBK 07-30-2025
- Dividend Yield
- BCRX N/A
- CLBK N/A
- EPS Growth
- BCRX N/A
- CLBK N/A
- EPS
- BCRX N/A
- CLBK N/A
- Revenue
- BCRX $503,485,000.00
- CLBK $176,914,000.00
- Revenue This Year
- BCRX $39.04
- CLBK $31.86
- Revenue Next Year
- BCRX $13.26
- CLBK $13.37
- P/E Ratio
- BCRX N/A
- CLBK N/A
- Revenue Growth
- BCRX 41.67
- CLBK N/A
- 52 Week Low
- BCRX $6.02
- CLBK $12.64
- 52 Week High
- BCRX $11.31
- CLBK $19.28
- Technical
- Relative Strength Index (RSI)
- BCRX 30.54
- CLBK 61.34
- Support Level
- BCRX $9.72
- CLBK $14.31
- Resistance Level
- BCRX $10.07
- CLBK $14.62
- Average True Range (ATR)
- BCRX 0.36
- CLBK 0.32
- MACD
- BCRX -0.20
- CLBK 0.10
- Stochastic Oscillator
- BCRX 4.63
- CLBK 89.27
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.